Lifecode seals $20.5 mln Series A
Foster City, California-based Lifecode Inc, a next-generation sequencing based molecular diagnostics company, has secured $20.5 million in Series A funding. Sequoia Capital, The Mayo Clinic and Mayo Ventures led the round.
20 February 2015•2 mins read
